← Eichor
Study identifier: NCT06711666 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease

Condition: Congenital Heart Disease · Cyanotic Congenital Heart Disease · d-Transposition of the Great Arteries  ·  Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

PhaseN/A
Planned participants174
Who can joinAll sexes, N/A to 50 Years
Healthy volunteersNo

About this study

Congenital heart disease (CHD) is the leading cause of congenital malformations, representing 1% of live births. Progress in surgical care have led to the dramatic increase in the population of children and adults living with heart disease. As survival is no longer a concern, long-term outcomes have become the major public health issue. Prenatal diagnosis of CHD requiring open-heart surgery can be a traumatic event for expecting mothers and fathers. In the general population, maternal mental health distress is associated with fetal disturbances in the hypothalamic-adrenal-pituitary system axis, restricted intrauterine growth and adverse outcomes in the offspring. It is unknown whether prenatal maternal psychological distress have an impact on neurodevelopmental outcomes in CHD. Our national study seeks to (1) characterize the impact of prenatal maternal psychological distress on neurodevelopmental outcomes at age 1 for children with CHD who undergo neonatal open-heart surgery; (2) investigate the sociodemographic and medical determinants associated with prenatal maternal mental health of women carrying a foetus diagnosed with complex CHD; (3) explore the mediating role of prenatal risk factors (i.e., sociodemographic, medical and maternal coping mechanisms) in the association of prenatal maternal mental health (i.e., distress, anxiety and depression) and neurodevelopment in children with CHD; and (4) explore the impact of paternal or the co-parent's mental health impact on ne…

This description comes directly from the study's public registry record.

Talk to the study team

Johanna Calderon, PhD  ·  330603830737  ·  johanna.calderon@inserm.fr

Always discuss trial participation with your own doctor first.

Locations (5)

Hopital de Marseille la TimoneMarseille, FranceRecruiting
CHU de MontpellierMontpellier, FranceRecruiting
Institut Saint PierrePalavas-les-Flots, FranceRecruiting
Hopital Necker Enfants MaladesParis, FranceRecruiting
Hopital Haut LevequePessac, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06711666